Lab Interpretation: Iron Deficiency Anemia with Chronic Kidney Disease
Your labs demonstrate iron deficiency anemia (IDA) complicated by stage 3B chronic kidney disease (CKD), requiring immediate oral or intravenous iron supplementation and investigation for blood loss, particularly given the urinary tract findings.
Primary Diagnosis: Iron Deficiency Anemia
Your iron studies definitively confirm iron deficiency:
- Serum iron: 9 µg/dL (critically low, normal 27-139)
- Ferritin: 16 ng/mL (depleted stores; <30 ng/mL confirms iron deficiency) 1
- Iron saturation: 3% (severely reduced; <16-20% indicates inadequate iron for red blood cell production) 1
- TIBC: 353 µg/dL (normal, appropriately elevated in iron deficiency)
- Transferrin: 308 mg/dL (elevated, consistent with iron deficiency)
The combination of ferritin <15 ng/mL with transferrin saturation <16% has 75% sensitivity and 98% specificity for absolute iron deficiency 1. Your values fall well below these thresholds, making the diagnosis unequivocal 2.
Anemia Characteristics
Your complete blood count reveals:
- Hemoglobin: 8.9 g/dL (low; normal 11.1-15.9 for females)
- Hematocrit: 32.1% (low; normal 34.0-46.6%)
- MCV: 93 fL (normal range, but misleading—see below)
- MCH: 25.7 pg (low; indicates hypochromic cells)
- MCHC: 27.7 g/dL (low; confirms hypochromia)
- RDW: 16.9% (elevated; indicates mixed red cell populations)
Critical interpretation point: Despite a normal MCV, you have iron deficiency anemia. The low MCH and MCHC confirm hypochromic red cells characteristic of IDA 1. The elevated RDW indicates a mixed population of older normal-sized cells and newer microcytic cells, which can mask the microcytosis and yield a falsely "normal" MCV 1. Hemoglobin and hematocrit are late indicators of iron deficiency—biochemical markers (ferritin, iron saturation) detect deficiency much earlier 1.
Complicating Factor: Chronic Kidney Disease
Your renal function is significantly impaired:
- Creatinine: 1.20 mg/dL (elevated; normal 0.57-1.00)
- eGFR: 45 mL/min/1.73m² (stage 3B CKD)
- BUN: 31 mg/dL (elevated; normal 8-27)
- BUN/Creatinine ratio: 26 (upper normal, suggests some prerenal component)
In CKD patients, anemia is multifactorial: erythropoietin deficiency from diseased kidneys combines with iron deficiency 3, 4. Your low total protein (5.3 g/dL) and borderline low albumin (3.7 g/dL) suggest possible chronic inflammation or malnutrition, which can elevate ferritin independent of true iron stores 1. However, your ferritin of 16 ng/mL is so profoundly low that iron deficiency is certain regardless of inflammation 5.
For CKD patients not on dialysis, ferritin <100 ng/mL with transferrin saturation <20% defines absolute iron deficiency 3, 6. You meet both criteria decisively.
Urinalysis Findings: Possible Blood Loss Source
Your urinalysis shows:
- WBC esterase: 2+ (abnormal)
- WBC: 11-30/hpf (elevated; normal 0-5)
- Trace ketones (mild, possibly from fasting or metabolic stress)
- Epithelial cells >10/hpf (suggests possible contamination or lower tract inflammation)
- No bacteria, RBCs, or nitrites
This pyuria (elevated WBCs) without bacteriuria suggests either:
- Urinary tract inflammation/infection (culture needed)
- Contamination from vaginal/perineal sources
- Interstitial nephritis contributing to CKD
The absence of hematuria makes urinary blood loss an unlikely cause of your iron deficiency, but occult gastrointestinal bleeding or menstrual blood loss are the most common culprits in premenopausal women 1, 2.
Other Laboratory Findings
- Vitamin D: 24.9 ng/mL (insufficient; optimal >30)
- HbA1c: 4.9% (normal; no diabetes)
- Lipids: Well-controlled
- Glucose: 73 mg/dL (normal)
- Electrolytes: Normal
- Liver function: Normal
Immediate Management Algorithm
Step 1: Identify and Address Blood Loss
You must be evaluated for:
- Gastrointestinal bleeding: Stool hemoccult testing, consider endoscopy if positive or if symptoms present (even with negative hemoccult, 62% of adults with IDA have GI lesions) 1
- Menstrual blood loss: Quantify menstrual flow; heavy menstrual bleeding is the leading cause in premenopausal women 2
- Urinary tract: Urine culture to rule out infection; repeat urinalysis after treatment if infection confirmed
Step 2: Iron Replacement Therapy
For CKD stage 3B with severe iron deficiency:
Option A: Oral iron (first-line if no contraindications)
- Ferrous sulfate 325 mg daily or every other day 2
- Alternate-day dosing may improve absorption and reduce side effects 2
- Limitation: Absorption may be impaired in CKD due to elevated hepcidin 5, 4
Option B: Intravenous iron (preferred in CKD)
- Indicated for: CKD patients with poor oral absorption, ongoing blood loss, or functional iron deficiency 4, 6, 2
- Dosing: 50-125 mg weekly for 8-10 doses, then reassess 3
- Target: Ferritin 100-500 ng/mL and transferrin saturation >20% in CKD patients 3, 6
Given your stage 3B CKD and severely depleted iron stores (ferritin 16 ng/mL), intravenous iron is likely more effective than oral supplementation 4, 6.
Step 3: Monitor Response
- Recheck CBC, ferritin, and iron saturation in 4-8 weeks
- Expected response: Hemoglobin increase of ≥1 g/dL confirms iron-deficiency anemia 1
- If no response: Consider functional iron deficiency, inflammatory block, or need for erythropoiesis-stimulating agents (ESAs) in CKD 3, 4
Step 4: Address CKD and Vitamin D
- Nephrology referral for CKD stage 3B management
- Vitamin D supplementation (currently insufficient at 24.9 ng/mL)
- Monitor renal function and proteinuria
Common Pitfalls to Avoid
Do not dismiss iron deficiency because MCV is normal. Low MCH/MCHC and elevated RDW confirm IDA despite normal MCV 7, 8.
Do not assume inflammation is masking iron stores. Your ferritin of 16 ng/mL is too low to be explained by inflammation alone; true iron deficiency is present 1, 5.
Do not overlook blood loss sources. Even without overt bleeding, occult GI or menstrual losses are common 1, 2.
Do not use oral iron alone in CKD without monitoring response. Impaired absorption and hepcidin elevation may necessitate IV iron 4, 6.
Do not ignore the urinary findings. Pyuria warrants urine culture and possible treatment [@clinical knowledge@].
Summary of Key Actions
- Investigate blood loss: GI evaluation, menstrual history, urine culture
- Start iron replacement: IV iron preferred given CKD; oral iron acceptable if IV unavailable
- Nephrology referral: CKD stage 3B requires specialist management
- Recheck labs in 4-8 weeks: Ferritin, iron saturation, CBC
- Supplement vitamin D: Target >30 ng/mL
- Treat urinary findings: Culture and antibiotics if infection confirmed